[Retracted] Isoquercitrin inhibits the progression of pancreatic cancer in vivo and in vitro by regulating opioid receptors and the mitogen‑activated protein kinase signalling pathway

Detalles Bibliográficos
Autores principales: Chen, Quan, Li, Ping, Xu, Yong, Li, Yang, Tang, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996682/
https://www.ncbi.nlm.nih.gov/pubmed/36825589
http://dx.doi.org/10.3892/or.2023.8505
_version_ 1784903097665978368
author Chen, Quan
Li, Ping
Xu, Yong
Li, Yang
Tang, Bo
author_facet Chen, Quan
Li, Ping
Xu, Yong
Li, Yang
Tang, Bo
author_sort Chen, Quan
collection PubMed
description
format Online
Article
Text
id pubmed-9996682
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-99966822023-03-10 [Retracted] Isoquercitrin inhibits the progression of pancreatic cancer in vivo and in vitro by regulating opioid receptors and the mitogen‑activated protein kinase signalling pathway Chen, Quan Li, Ping Xu, Yong Li, Yang Tang, Bo Oncol Rep Retraction D.A. Spandidos 2023-02-20 /pmc/articles/PMC9996682/ /pubmed/36825589 http://dx.doi.org/10.3892/or.2023.8505 Text en Copyright: © Chen et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
spellingShingle Retraction
Chen, Quan
Li, Ping
Xu, Yong
Li, Yang
Tang, Bo
[Retracted] Isoquercitrin inhibits the progression of pancreatic cancer in vivo and in vitro by regulating opioid receptors and the mitogen‑activated protein kinase signalling pathway
title [Retracted] Isoquercitrin inhibits the progression of pancreatic cancer in vivo and in vitro by regulating opioid receptors and the mitogen‑activated protein kinase signalling pathway
title_full [Retracted] Isoquercitrin inhibits the progression of pancreatic cancer in vivo and in vitro by regulating opioid receptors and the mitogen‑activated protein kinase signalling pathway
title_fullStr [Retracted] Isoquercitrin inhibits the progression of pancreatic cancer in vivo and in vitro by regulating opioid receptors and the mitogen‑activated protein kinase signalling pathway
title_full_unstemmed [Retracted] Isoquercitrin inhibits the progression of pancreatic cancer in vivo and in vitro by regulating opioid receptors and the mitogen‑activated protein kinase signalling pathway
title_short [Retracted] Isoquercitrin inhibits the progression of pancreatic cancer in vivo and in vitro by regulating opioid receptors and the mitogen‑activated protein kinase signalling pathway
title_sort [retracted] isoquercitrin inhibits the progression of pancreatic cancer in vivo and in vitro by regulating opioid receptors and the mitogen‑activated protein kinase signalling pathway
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996682/
https://www.ncbi.nlm.nih.gov/pubmed/36825589
http://dx.doi.org/10.3892/or.2023.8505
work_keys_str_mv AT chenquan retractedisoquercitrininhibitstheprogressionofpancreaticcancerinvivoandinvitrobyregulatingopioidreceptorsandthemitogenactivatedproteinkinasesignallingpathway
AT liping retractedisoquercitrininhibitstheprogressionofpancreaticcancerinvivoandinvitrobyregulatingopioidreceptorsandthemitogenactivatedproteinkinasesignallingpathway
AT xuyong retractedisoquercitrininhibitstheprogressionofpancreaticcancerinvivoandinvitrobyregulatingopioidreceptorsandthemitogenactivatedproteinkinasesignallingpathway
AT liyang retractedisoquercitrininhibitstheprogressionofpancreaticcancerinvivoandinvitrobyregulatingopioidreceptorsandthemitogenactivatedproteinkinasesignallingpathway
AT tangbo retractedisoquercitrininhibitstheprogressionofpancreaticcancerinvivoandinvitrobyregulatingopioidreceptorsandthemitogenactivatedproteinkinasesignallingpathway

Ejemplares similares